C07C 233/41
With the substituted hydrocarbon radical bound to the nitrogen atom of the
Official title: with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
C07C233/41 (With the substituted hydrocarbon radical bound to the nitrogen atom of the) appears on 70 US grants and 60 published applications in this corpus.
Search patents in C07C- Granted patents
- 70
- Published applications
- 60
- Assignees
- 56
- Inventors
- 285
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 3 |
| 2004 | 1 | 1 |
| 2005 | 0 | 2 |
| 2006 | 4 | 4 |
| 2007 | 2 | 2 |
| 2008 | 2 | 4 |
| 2009 | 1 | 2 |
| 2010 | 0 | 1 |
| 2011 | 2 | 0 |
| 2012 | 2 | 2 |
| 2013 | 0 | 3 |
| 2014 | 2 | 5 |
| 2015 | 0 | 2 |
| 2016 | 7 | 6 |
| 2017 | 6 | 4 |
| 2018 | 2 | 2 |
| 2019 | 3 | 4 |
| 2020 | 3 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 2 |
| 2023 | 1 | 1 |
| 2024 | 0 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Inhibitors of YAP/TAZ-TEAD oncoproteins, synthesis and use thereof24 Mar 2026US 12,583,815 B2BridGene Biosciences, Inc.
- Adamantane derivatives for the treatment of filovirus infection4 Mar 2025US 12,240,857 B2Arisan Therapeutics Inc.
- Substituted bicyclic compounds18 Jul 2023US 11,701,373 B2Bristol-Myers Squibb Company
- Substituted bicyclic compounds13 Jul 2021US 11,058,696 B2Bristol-Myers Squibb Company
- Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof17 Nov 2020US 10,836,743 B2Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Cyclohexyl or heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia17 Sep 2026US 2026/0274785 A1Atrogi AB
- Amino lipid compound, preparation method therefor, and use thereof15 Jan 2026US 2026/0015311 A1Shenzhen Shenxin Biotechnology Co., Ltd.
- (aza)spiroheptane derivatives for the treatment of neurodegenerative disorders25 Dec 2025US 2025/0388592 A1Remynd NV
- (meth)acrylamide compound, monomer composition, composition for dental material, and dental material24 Apr 2025US 2025/0127690 A1Mitsui Chemicals, Inc.
- Cyclohexyl beta-hydroxy alkyl amines and medical uses thereof28 Nov 2024US 2024/0390298 A1Atrogi AB
Most cited
By later US patents
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- Polyamine derivatives of 1-aminoindan28US 5,646,188 ATeva Pharmaceutical Industries Ltd. · 1997
- Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging19US 5,292,938 AAssociated Universities, Inc. · 1994
- 2-amino-1,3-propanediol compound and immunosuppressant18US 5,719,176 ATaito Co., Ltd. · 1998
- Cyclopentene derivatives useful as antagonists of the motilin receptor15US 5,972,939 AOrtho-McNeil Pharmaceutical, Inc. · 1999